I am a medical oncologist and hematologist specializing in the care of people with multiple myeloma and related plasma cell disorders. With my colleagues at Memorial Sloan Kettering Cancer Center, I am focused on identifying optimal treatment strategies for people with these disorders. I am interested in the molecular pathways underlying progression of plasma cell disorders and the development of targeted strategies aiming to delay, prevent, and cure full-blown disease. I also have an interest in health policy as it relates to oncologic drug approvals and the cost of cancer care.
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Sham Mailankody
Clinical Trials Co-Investigated by Sham Mailankody
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more